随着本次产品上新，CST目前可以提供接近6000种小包装一抗（20uL），以及超过370种覆盖不同信号通路以及研究领域的小包装抗体套装（Antibody Sampler Kit）。 CST于9月17日全新推出了近4000种小包装一抗（20uL）。随着本次产品上新，CST目前可以提供接近6000种小包装一 ...

In March 2022, AmoyDx received approval for the company’s PD-L1 Expression Detection Kit (IHC), which leverages the CST PD-L1 antibody validated for immunohistochemistry (IHC) and is used to ...

and cell signaling, creating robust demand for antibody and protein labeling kits. Growth of Proteomics and Genomics: High-throughput protein analysis and the need to understand protein ...

Cell Signaling Technology, Inc. (CST) of Danvers, MA, announced today that it has introduced a highly specific HER3 rabbit monoclonal antibody (mAb), an important addition for researchers studying ...

Rising Investments in Biomedical Research: Global academic and commercial research institutions are increasingly focused on molecular biology, immunology, and cell signaling, creating robust demand ...

--(BUSINESS WIRE)--Cell Signaling Technology (CST), a leading provider of antibodies, kits and services ... second year in a row with the award for “Antibody Company of the Year.” ...

This partnership enables the use of over 1,700 IHC-validated antibodies from CST detected by fluorescent secondary antibodies for use on the COMET, empowering researchers to develop antibody ...

SINGAPORE: A rapid antibody test kit for COVID-19 that can be used to identify asymptomatic people and produces “accurate” results in 15 minutes has been developed and manufactured in Singapore.

Drug major Cipla has signed a licensing agreement with a Belgium-based firm, Multi G for the distribution of their COVID-19 rapid antibody test kit across most emerging markets and Europe.